We are live on ! Find out more
NAP

New Amsterdam Partners Portfolio holdings

AUM $272M
1-Year Est. Return 12.21%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+12.21%
3 Year Est. Return
+73.94%
5 Year Est. Return
+120.95%
10 Year Est. Return
AUM
$1.15B
AUM Growth
-$345M
Cap. Flow
-$436M
Cap. Flow %
-37.98%
Top 10 Hldgs %
24.27%
Holding
144
New
25
Increased
32
Reduced
55
Closed
30

Top Buys

Rank Stock Value
1
ESND
Essendant Inc.
ESND
+$25.9M
2
RES icon
RPC Inc
RES
+$21M
3
FOSL icon
Fossil Group
FOSL
+$20.8M
4
BKE icon
Buckle
BKE
+$20.3M
5
ILG
ILG, Inc Common Stock
ILG
+$19.3M

Top Sells

Rank Stock Value
1
DLX icon
Deluxe
DLX
+$37M
2
PRLB icon
Protolabs
PRLB
+$31.3M
3
LOPE icon
Grand Canyon Education
LOPE
+$24.6M
4
UTHR icon
United Therapeutics
UTHR
+$22.7M
5
BID
Sotheby's
BID
+$22.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.89%
2 Technology 19.9%
3 Industrials 13.51%
4 Healthcare 13.1%
5 Financials 12.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
76
Meta Platforms (Facebook)
META
$1.47T
$3.68M 0.32%
47,192
+87
+0.2% +$6.65K
AMSG
77
DELISTED
Amsurg Corp
AMSG
$3.64M 0.32%
66,548
-108,695
-62% -$5.54M
MANH icon
78
Manhattan Associates
MANH
$13B
$3.63M 0.32%
89,095
+7,600
+9% +$291K
ROK icon
79
Rockwell Automation
ROK
$47.8B
$3.61M 0.31%
+32,441
New +$3.56M
MTD icon
80
Mettler-Toledo International
MTD
$28B
$3.59M 0.31%
11,872
+2
+0% +$550
HSY icon
81
Hershey
HSY
$36B
$3.53M 0.31%
33,956
+2
+0% +$195
CMI icon
82
Cummins
CMI
$77.8B
$3.52M 0.31%
24,421
-41
-0.2% -$5.8K
VRTU
83
DELISTED
Virtusa Corporation
VRTU
$3.51M 0.31%
84,267
-22,634
-21% -$880K
NUS icon
84
Nu Skin
NUS
$236M
$3.46M 0.3%
79,184
-139,582
-64% -$6.16M
OME
85
DELISTED
Omega Protein
OME
$3.45M 0.3%
326,700
-12,027
-4% -$142K
ECL icon
86
Ecolab
ECL
$80.4B
$3.44M 0.3%
32,903
+2
+0% +$219
BBBY
87
DELISTED
Bed Bath & Beyond Inc
BBBY
$3.39M 0.3%
+44,530
New +$3.11M
BIIB icon
88
Biogen
BIIB
$32.3B
$3.37M 0.29%
9,941
WFC icon
89
Wells Fargo
WFC
$262B
$3.33M 0.29%
60,715
+5
+0% +$265
ESRX
90
DELISTED
Express Scripts Holding Company
ESRX
$3.3M 0.29%
38,994
-7,482
-16% -$585K
DGX icon
91
Quest Diagnostics
DGX
$26.8B
$3.21M 0.28%
+47,888
New +$3.02M
DXPE icon
92
DXP Enterprises
DXPE
$2.88B
$3.18M 0.28%
62,859
+21,907
+53% +$1.31M
DE icon
93
Deere & Co
DE
$170B
$3.08M 0.27%
34,822
-77
-0.2% -$6.65K
TRV icon
94
Travelers Companies
TRV
$77.2B
$3.03M 0.26%
28,617
+1
+0% +$101
MKC icon
95
McCormick & Company Non-Voting
MKC
$14.9B
$3.01M 0.26%
+81,068
New +$2.9M
ECPG icon
96
Encore Capital Group
ECPG
$2.1B
$2.98M 0.26%
+67,129
New +$2.89M
MSFT icon
97
Microsoft
MSFT
$3.81T
$2.93M 0.26%
63,064
+8
+0% +$376
GWW icon
98
W.W. Grainger
GWW
$61.5B
$2.92M 0.25%
11,443
+506
+5% +$125K
LHCG
99
DELISTED
LHC Group LLC
LHCG
$2.91M 0.25%
+93,268
New +$2.35M
BID
100
DELISTED
Sotheby's
BID
$2.9M 0.25%
67,179
-570,709
-89% -$22.5M

Similar funds

New Amsterdam Partners's Q4 2014 Portfolio in Review

As of Q4 2014, New Amsterdam Partners held 144 positions worth $1.15B, down 23% from $1.49B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New Amsterdam Partners withdrew a net $436M in Q4 2014, closing 30 positions and reducing 55 holdings. Its most notable exit was Deluxe, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, New Amsterdam Partners opened a new position in Essendant Inc. worth $26.8M.

  • New Amsterdam Partners's largest Q4 2014 buy was Essendant Inc.: 635,012 shares worth $26.8M.
  • New Amsterdam Partners added most to Lannett Company, Inc. in Q4 2014, an estimated $11M increase.
  • New Amsterdam Partners's biggest Q4 2014 reduction was Protolabs, cutting an estimated $31.3M.
  • New Amsterdam Partners fully exited Deluxe in Q4 2014, selling an estimated $37M.
  • New Amsterdam Partners's ten largest holdings make up 24% of its $1.15B portfolio in Q4 2014.
  • New Amsterdam Partners opened 25 new positions and closed 30 in Q4 2014.
  • New Amsterdam Partners's portfolio value fell 23% quarter-over-quarter to $1.15B.

Based on New Amsterdam Partners's 13F filing for Q4 2014, filed 9 Feb 2015.